Compare LGND & VCTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LGND | VCTR |
|---|---|---|
| Founded | 1987 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.1B |
| IPO Year | 1997 | 2018 |
| Metric | LGND | VCTR |
|---|---|---|
| Price | $316.86 | $126.14 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 7 |
| Target Price | ★ $361.27 | $129.33 |
| AVG Volume (30 Days) | 185.1K | ★ 539.4K |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 1.58% |
| EPS Growth | ★ 2886.36 | N/A |
| EPS | 0.31 | ★ 4.11 |
| Revenue | $141,102,000.00 | ★ $413,412,000.00 |
| Revenue This Year | $8.82 | $25.02 |
| Revenue Next Year | $31.67 | $30.91 |
| P/E Ratio | $1,019.68 | ★ $30.84 |
| Revenue Growth | ★ 29.48 | 0.92 |
| 52 Week Low | $175.89 | $60.74 |
| 52 Week High | $326.63 | $129.31 |
| Indicator | LGND | VCTR |
|---|---|---|
| Relative Strength Index (RSI) | 55.75 | 67.20 |
| Support Level | $277.97 | $82.27 |
| Resistance Level | $319.83 | N/A |
| Average True Range (ATR) | 11.45 | 4.88 |
| MACD | -0.28 | 1.67 |
| Stochastic Oscillator | 67.94 | 88.52 |
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Victory Capital Holdings Inc is a diversified investment management firm. The company provides specialized investment strategies to institutions, intermediaries, retirement platforms and individual investors. Its offerings include actively and passively managed mutual funds, rules-based and active exchange traded funds (ETFs), institutional separate accounts, variable insurance products (VIPs), alternative investments, private closed end funds, and a 529 Education Savings Plan. The company operates in one operating and reportable segment that provides investment management services and products to institutional, intermediary, retirement platforms and individual investors. The majority of the company's revenue consists of Investment management fees.